Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease
Laura Amo, Elena Sánchez‐López(Centro de Investigación Biomédica en Red), Marta Espina(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Miren Ettcheto(Universitat de Barcelona), Eliana B. Souto(University College Dublin), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), María L. García(Biomedical Research Networking Center on Neurodegenerative Diseases), Amanda Cano(Biomedical Research Networking Center on Neurodegenerative Diseases)
Cited by 64
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
|International Journal of Pharmaceutics|2004|664
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
|Journal of Controlled Release|2019|330
Microemulsions and Nanoemulsions in Skin Drug Delivery
|Bioengineering|2022|291